U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
110311110311Suture Fixation System Versus Tendonous Reconstruction in Carpometacarpal (CMC) ArthroplastyRecruitingNo Results AvailableThumb Carpometacarpal ArthritisProcedure: Ligament reconstruction with suture fixation system|Procedure: Ligament Reconstruction with Tendon Interposition (LRTI)https://ClinicalTrials.gov/show/NCT01121874
110312110312Prospective Comparative Study of Refractive Outcome of STAAR and Alcon Toric Intraocular LensesCompletedNo Results AvailableAstigamtismProcedure: Phacoemulsification with implantation of toric IOLhttps://ClinicalTrials.gov/show/NCT01121861
110313110313Randomized Study With Oxaliplatin in 2nd Line Pancreatic CancerCompletedNo Results AvailablePancreatic NeoplasmsDrug: Leucovorin|Drug: OXALIPLATIN|Drug: 5-Fluorouracilhttps://ClinicalTrials.gov/show/NCT01121848
110314110314Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative StudyCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: INSULIN GLARGINE|Drug: INSULIN GLULISINE|Drug: PREMIXED INSULINhttps://ClinicalTrials.gov/show/NCT01121835
110315110315Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)CompletedNo Results AvailableInfluenzaBiological: Influenza virus vaccine (split virion, inactivated)|Biological: Influenza virus vaccine (split virion, inactivated)https://ClinicalTrials.gov/show/NCT01121822
110316110316Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once DailyCompletedNo Results AvailableHIV-1 Infection|HIV InfectionsDrug: Raltegravir|Drug: Etravirinehttps://ClinicalTrials.gov/show/NCT01121809
110317110317Influence of Vitamin D on Inflammatory Bowel Disease RemissionNot yet recruitingNo Results AvailableInflammatory Bowel DiseaseDietary Supplement: Vitamin D|Other: Water or milk|Dietary Supplement: Vitamin D enriched milkhttps://ClinicalTrials.gov/show/NCT01121796
110318110318The Effect of Lactisole on the Responses to Glucose SolutionRecruitingNo Results AvailableBlood Glucose|Appetite|Therapeutic Uses|HormonesOther: Lactisole|Dietary Supplement: Lactisole|Dietary Supplement: Lactisole|Dietary Supplement: Lactisolehttps://ClinicalTrials.gov/show/NCT01121783
110319110319"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"CompletedNo Results AvailableRenal InsufficiencyDrug: fondaparinux sodium injectionhttps://ClinicalTrials.gov/show/NCT01121770
110320110320Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone LymphomaActive, not recruitingHas ResultsFollicular Lymphoma|Marginal Zone LymphomaDrug: azacitidine|Drug: lenalidomidehttps://ClinicalTrials.gov/show/NCT01121757
110321110321Supralimus-Coreâ„¢ Pharmacokinetic (PK) StudyCompletedNo Results AvailableCoronary Artery DiseaseDevice: Supralimus-Coreâ„¢ Sirolimus eluting Coronary Stenthttps://ClinicalTrials.gov/show/NCT01121744
110322110322A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis CCompletedNo Results AvailableChronic Hepatitis C Virus Infection|Genotype 1|Treatment-Experienced Patients|RelapsesDrug: Interferon α-5|Drug: Interferon-α5 plus Interferon-α 2b|Drug: Interferon α-2b (INTRON® A)https://ClinicalTrials.gov/show/NCT01121731
110323110323NIR-Guided Sentinel Lymph Node Mapping in MelanomaCompletedNo Results AvailableMelanomaProcedure: Sentinel Lymph Node Mappinghttps://ClinicalTrials.gov/show/NCT01121718
110324110324Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)CompletedNo Results AvailableChronic HepatitisDrug: Peg Interferon alpha2b + Ribavirinhttps://ClinicalTrials.gov/show/NCT01121705
110325110325Venue-Based Couples CoOp in South AfricaCompletedNo Results AvailableAlcoholism|HIV InfectionsBehavioral: Couples Intervention|Behavioral: Women's CoOp|Behavioral: Women's CoOp and Men's Interventionhttps://ClinicalTrials.gov/show/NCT01121692
110326110326French Observatory on Hospitalizations in Cardiology of Patients of 80 Years and OverCompletedNo Results AvailableCardiovascular Diseasehttps://ClinicalTrials.gov/show/NCT01121679
110327110327Multi-centre Study to Compare Efficacy and Safety of AFOLIA and Gonal-f in Women for Assisted Reproductive TreatmentCompletedNo Results AvailableInfertilityDrug: Follitropin alfahttps://ClinicalTrials.gov/show/NCT01121666
110328110328Impact of Oral Magnesium on Neuropathic PainCompletedNo Results AvailablePatient With Neuropathic PainDrug: Magnogene ® (magnesium)https://ClinicalTrials.gov/show/NCT01121653
110329110329A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk WomenActive, not recruitingNo Results AvailableEpithelial Ovarian CancerProcedure: CA125 assay on Abbott Architect i1000SR platform|Procedure: HE4 assay on Architect i1000SR platform|Procedure: Transvaginal Ultrasoundhttps://ClinicalTrials.gov/show/NCT01121640
110330110330Computer-based Cognitive Training for Parkinson DiseaseCompletedNo Results AvailableParkinson Disease|GaitOther: Computerized cognitive traininghttps://ClinicalTrials.gov/show/NCT01121627
110331110331Mesenteric Vessel Sealing by Three InstrumentsCompletedNo Results AvailableSurgeryDevice: LOTUS|Device: Ethicon Harmonic Scalpel|Device: LigaSure bipolar vessel sealing devicehttps://ClinicalTrials.gov/show/NCT01121614
110332110332CoSeal in Liver and Biliary Surgery in Prevention of Denovo Hepatic AdhesionTerminatedNo Results AvailablePatient With Hepatic MetastasisProcedure: hepatic surgery of resection|Procedure: hepatic surgery of resectionhttps://ClinicalTrials.gov/show/NCT01121601
110333110333An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)Active, not recruitingNo Results AvailableNeoplasms MalignantDrug: Crizotinibhttps://ClinicalTrials.gov/show/NCT01121588
110334110334A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung CancerCompletedHas ResultsNon Small Cell Lung CancerDrug: PF-02341066|Drug: PF-00299804|Drug: PF-02341066|Drug: PF-00299804https://ClinicalTrials.gov/show/NCT01121575
110335110335Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsCompletedHas ResultsPancreatic Neuroendocrine TumorsDrug: Sunitinibhttps://ClinicalTrials.gov/show/NCT01121562
110336110336A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast CancerTerminatedHas ResultsInvasive Early Breast CancerDrug: Aromasinhttps://ClinicalTrials.gov/show/NCT01121549
110337110337Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedHas ResultsDepressionDrug: Armodafinilhttps://ClinicalTrials.gov/show/NCT01121536
110338110338Cue-based Tactile Stimulation and Infant Stress ReactivityRecruitingNo Results AvailableInfant, PrematureBehavioral: Cue directed tactile stimulationhttps://ClinicalTrials.gov/show/NCT01121523
110339110339Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 SystemWithdrawnNo Results AvailableCoagulation|Therapeutic Uses|Pharmacologic ActionsDevice: closure devicehttps://ClinicalTrials.gov/show/NCT01121510
110340110340The Effect of Physostigmine on Cognitive Functioning in the Immediate Period After Sedation for ColonoscopyNot yet recruitingNo Results AvailableCognitive DysfunctionDrug: Physostigminehttps://ClinicalTrials.gov/show/NCT01121497

* Görseller ve İçerik tekif hakkına sahip olabilir